These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8617434

  • 1. Effects of long-term administration of octreotide in portal vein-stenosed rats.
    Lin HC, Yang MC, Hou MC, Li SM, Huang YT, Yu PC, Tsai YT, Lee SD.
    Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
    Yang YY, Lin HC, Huang YT, Hou MC, Lee FY, Chang FY, Lee SD.
    J Hepatol; 2005 May; 42(5):652-8. PubMed ID: 15826713
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH, Nishida O, Tokubayashi M, Kimura F, Takimoto Y, Yoshioka H, Inque R, Kita T.
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [Abstract] [Full Text] [Related]

  • 5. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H, Xu J, Liu H, Meng FB, Qiu JF, Wu ZY.
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [Abstract] [Full Text] [Related]

  • 6. [Effects of sandostatin on gastric mucosal perfusion in rats with portal hypertensive gastropathy].
    Le Q, Zhang X, Zhang J.
    Zhonghua Gan Zang Bing Za Zhi; 2000 Feb; 8(1):21-3. PubMed ID: 10712778
    [Abstract] [Full Text] [Related]

  • 7. Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis.
    Lin HC, Huang YT, Cheng YR, Hou MC, Lee FY, Chang FY, Tsai YT, Lee SD.
    Clin Sci (Lond); 1998 Jun; 94(6):645-50. PubMed ID: 9854463
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodés J, Bosch J.
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [Abstract] [Full Text] [Related]

  • 9. Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats.
    Lin HC, Soubrane O, Cailmail S, Lebrec D.
    J Hepatol; 1991 Sep; 13(2):213-9. PubMed ID: 1744426
    [Abstract] [Full Text] [Related]

  • 10. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J, Cao H, Liu H, Wu ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [Abstract] [Full Text] [Related]

  • 11. Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats.
    Sieber CC, Lee FY, Groszmann RJ.
    Hepatology; 1996 May; 23(5):1218-23. PubMed ID: 8621156
    [Abstract] [Full Text] [Related]

  • 12. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J.
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [Abstract] [Full Text] [Related]

  • 13. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
    Vorobioff JD, Ferretti SE, Zangroniz P, Gamen M, Picabea E, Bessone FO, Reggiardo V, Diez AR, Tanno M, Cuesta C, Tanno HE.
    Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of 8-day DL-028 and octreotide administration in rats with portal hypertension.
    Huang YT, Wu HL, Chern JW, Lin HC, Hong CY.
    Scand J Gastroenterol; 1998 Dec; 33(12):1303-9. PubMed ID: 9930395
    [Abstract] [Full Text] [Related]

  • 15. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L, Giostra E, Frossard JL, Morard I, Mentha G, Hadengue A.
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [Abstract] [Full Text] [Related]

  • 16. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats.
    Fort J, Oberti F, Pilette C, Veal N, Gallois Y, Douay O, Rousselet MC, Rosenbaum J, Calès P.
    Hepatology; 1998 Dec; 28(6):1525-31. PubMed ID: 9828216
    [Abstract] [Full Text] [Related]

  • 17. Vascular actions of octreotide in the portal hypertensive rat.
    Aboud RW, Connolly C, McCormick PA, Docherty JR.
    Br J Pharmacol; 1997 Oct; 122(4):698-702. PubMed ID: 9375966
    [Abstract] [Full Text] [Related]

  • 18. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z, Zhou J, Chen Z, Zhou H, Jiao Z, Kuang Y, Yuan J, Wang Q, Zeng M.
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [Abstract] [Full Text] [Related]

  • 19. Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis.
    Lin HC, Huang YT, Wu HL, Lee WC, Hou MC, Lee FY, Chang FY, Lee SD.
    J Hepatol; 1999 Sep; 31(3):482-8. PubMed ID: 10488708
    [Abstract] [Full Text] [Related]

  • 20. Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat.
    Braillon A, Lee SS, Girod C, Peignoux-Martinot M, Valla D, Lebrec D.
    J Lab Clin Med; 1986 Dec; 108(6):543-8. PubMed ID: 3783027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.